Q: What looks cheap in the BE portfolio? Thanks.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: 5i Team -
Can you please provide your analysis on Whitecap Resources? What is their debt/cash flow? Can they survive with $30 WTI over the next Year? How does WCP stack up against CPG? Thank You!
Can you please provide your analysis on Whitecap Resources? What is their debt/cash flow? Can they survive with $30 WTI over the next Year? How does WCP stack up against CPG? Thank You!
Q: Was looking at this utility: TTM PE=16, P/B of .93, low debt/equity of 16%, low ROE of 7% and a P/R of 92%. Price has gone up a lot lately - not sure why as EPS on a Q basis has not been that stellar as indicated by low ROE. I already own FTS as my utility unless you count ENB and TRP: so, I know you like - but, why as it seems to be of less quality as the afore mentioned.
Q: Greetings 5i Team,
I have been patiently (no pun intended) waiting for this company to bounce back after all bumps it went through the past year. As things were looking good at the beginning of the year (due to positive year end results), it has taken another step back recently due to what's been happening to markets around the world. I was wondering if it's a good idea/time to dilute the price of my $0.95 cost/share now. Thank you for your time.
I have been patiently (no pun intended) waiting for this company to bounce back after all bumps it went through the past year. As things were looking good at the beginning of the year (due to positive year end results), it has taken another step back recently due to what's been happening to markets around the world. I was wondering if it's a good idea/time to dilute the price of my $0.95 cost/share now. Thank you for your time.
Q: Hi Peter and Gang,
Would you please comment on PLI's clinical developments that are currently on their plates in terms of their nature and their target completion dates.
Thanks.
Harry
Would you please comment on PLI's clinical developments that are currently on their plates in terms of their nature and their target completion dates.
Thanks.
Harry
Q: Would you consider a rethink on the growth portfolio not only regards the constituent holdings but the whole portfolio as a percentage of the total investment? I ask this in light of the increasing probability of the following economic conditions:
1. The oil price remains depressed for the entire year with the western provinces in recession and the Canadian GDP also contracts for two quarters or more.
2. The steep decline in shale production and the rate increase in the US would have a significant negative impact on the Russell Index IWO which maybe in bear territory?
Assuming that any given individual’s investment in the growth portfolio is according to her risk profile, would you suggest adjustments to the overall portfolio weight (increase or decrease) in proportion to the balanced and income portfolios; and the individual growth stocks for 2016? If you would, then can you please try to indicate exposure to specific sectors/regions/stocks?
Regards.
1. The oil price remains depressed for the entire year with the western provinces in recession and the Canadian GDP also contracts for two quarters or more.
2. The steep decline in shale production and the rate increase in the US would have a significant negative impact on the Russell Index IWO which maybe in bear territory?
Assuming that any given individual’s investment in the growth portfolio is according to her risk profile, would you suggest adjustments to the overall portfolio weight (increase or decrease) in proportion to the balanced and income portfolios; and the individual growth stocks for 2016? If you would, then can you please try to indicate exposure to specific sectors/regions/stocks?
Regards.
Q: Good Morning 5i
Could you comment on the forward guidance offered by IT this morning? Thanks.
Could you comment on the forward guidance offered by IT this morning? Thanks.
Q: I know that you have a high regard for PLI. I am wondering if it could be a potential take-over target? I believe I read some time ago that one shareholder had a very large position which I assume could put a damper on take-over activity. Your advice is always so helpful.
Thank you,Peter
Thank you,Peter
Q: in this horrible tape kinaxis is hitting new 52 week highs, it is an expensive stock , i have owned it since 30. dollars, there is no news except so e executive appointments,would you buy more here, i like to overweight when stocks hit 52 week highs especially in a bad tape. dave
Q: I cannot find any reason for KXS's +5.5% rise happening now.
Any input?
Any input?
Q: Happy New Year Peter. I thoroughly enjoy your service.
I bought EFN in May of 2015. It is about to hit my "25% Mental Trailing Stop" when I have to re-evaluate this stock as to whether or not to sell it at market price. It is currently at 24.4% while my actual loss is 15%. I use Trailing stops to limit my losses. It has worked very well for me. I have an option to raise my "trailing stop" after the evaluation to a higher level. What's your current view of EFN, the good and bad?
I bought EFN in May of 2015. It is about to hit my "25% Mental Trailing Stop" when I have to re-evaluate this stock as to whether or not to sell it at market price. It is currently at 24.4% while my actual loss is 15%. I use Trailing stops to limit my losses. It has worked very well for me. I have an option to raise my "trailing stop" after the evaluation to a higher level. What's your current view of EFN, the good and bad?
Q: With cash available in my TFSA and markets down, what are your top 3 picks for value at this point from each of your portfolios? Thanks!
Q: With the market sell off again, can you suggest 5 stocks in either of the portfolios in the best position for a quick rebound once the market settles down and with a balance risk/reward leaning to conservative. A dividend would also be nice.
Q: Should the earnings in the portfolios be a percentage instead of a dollar amount, or is there a dollar amount for the portfolios.
Q: Because of the US threatning to crack down on corporate inversions and CXR's current share price, do you see it as an M&A target in 2016?
Q: PLI has been very strong without any news that I can find. What is your current view on it's prospect?
Regards, Peter
Regards, Peter
Q: Could you comment on what pick and pay will mean to BCE as far as the stock price is concerned...
Q: Would it make sense to construct my portfolio buying all the A rating for companies under 5iResearch coverage and to diversify I would pick some of the B rated companies, replace them as you eliminate or down grade them?
Thanks
Thanks
Q: Happy new year Peter and Ryan,
Looking to add a non cyclical consumer goods and was hoping to find it in your growth portfolio. Did i miss it as I couldn t find one.
Thank you and I look forward to your guidance through these troubled waters.
Looking to add a non cyclical consumer goods and was hoping to find it in your growth portfolio. Did i miss it as I couldn t find one.
Thank you and I look forward to your guidance through these troubled waters.
Q: Looking to add a financial stock. I am trying to stay within the growth portfolio so I am leaning towards cxi and efn. I am thinking GUD could also fall under this category since they essentially borrow to the health care industry.
Thank you and i appreciate you re guidance.
Thank you and i appreciate you re guidance.